Durvalumab vs Lansoprazole

Durvalumab vs Lansoprazole: Overview

This comparison examines the pharmacological differences between Durvalumab and Lansoprazole.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Lansoprazole: Proton pump inhibitor.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Lansoprazole — 1.5 hours.

Chemical Properties

Molecular Formula: Lansoprazole — C16H14F3N3O2S.

Molecular Weight: Lansoprazole — 369.3620 g/mol.

Type: Durvalumab — Antibody; Lansoprazole — Small molecule.